AYURF (Ayurcann Holdings) Gross Margin %: 26.37% (As of Sep. 2025) — 19% Below Median


What is Ayurcann Holdings Gross Margin %?

Ayurcann Holdings AYURF Gross Margin % is 26.37% as of Sep. 2025, which is 19% below its 10-year median of 32.66. The stock has 2 warning signs investors should review.

Gross Margin % is calculated as gross profit divided by its revenue. Ayurcann Holdings's Gross Profit for the three months ended in Sep. 2025 was $1.62 Mil. Ayurcann Holdings's Revenue for the three months ended in Sep. 2025 was $6.13 Mil. Therefore, Ayurcann Holdings's Gross Margin % for the quarter that ended in Sep. 2025 was 26.37%.


The historical rank and industry rank for Ayurcann Holdings's Gross Margin % or its related term are showing as below:

AYURF' s Gross Margin % Range Over the Past 10 Years
Min: 23.66   Med: 32.66   Max: 60.61
Current: 28.92


During the past 13 years, the highest Gross Margin % of Ayurcann Holdings was 60.61%. The lowest was 23.66%. And the median was 32.66%.

AYURF's Gross Margin % is not ranked
in the Drug Manufacturers industry.
Industry Median: 48.46 vs AYURF: 28.92

Ayurcann Holdings had a gross margin of 26.37% for the quarter that ended in Sep. 2025 => Competition eroding margins

The 5-Year average Growth Rate of Gross Margin for Ayurcann Holdings was 0.00% per year.


Ayurcann Holdings  (OTCPK:AYURF) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Ayurcann Holdings had a gross margin of 26.37% for the quarter that ended in Sep. 2025 => Competition eroding margins


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Ayurcann Holdings Gross Margin % Related Terms


Ayurcann Holdings Gross Margin % Historical Data

* Premium members only.

The historical data trend for Ayurcann Holdings's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ayurcann Holdings Gross Margin % Chart

Ayurcann Holdings Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Jun21 Jun22 Jun23 Jun24 Jun25
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 60.61 23.67 29.46 33.65 32.66

Ayurcann Holdings Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 39.99 43.62 37.91 8.68 26.37

AYURF vs BSPK, SKYI, CPMD: Gross Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Ayurcann Holdings's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ayurcann Holdings Gross Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ayurcann Holdings's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Ayurcann Holdings's Gross Margin % falls into.



Ayurcann Holdings Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Ayurcann Holdings's Gross Margin for the fiscal year that ended in Jun. 2025 is calculated as

Gross Margin % (A: Jun. 2025 )=Gross Profit (A: Jun. 2025 ) / Revenue (A: Jun. 2025 )
=7.4 / 22.761
=(Revenue - Cost of Goods Sold) / Revenue
=(22.761 - 15.327) / 22.761
=32.66 %

Ayurcann Holdings's Gross Margin for the quarter that ended in Sep. 2025 is calculated as


Gross Margin % (Q: Sep. 2025 )=Gross Profit (Q: Sep. 2025 ) / Revenue (Q: Sep. 2025 )
=1.6 / 6.128
=(Revenue - Cost of Goods Sold) / Revenue
=(6.128 - 4.512) / 6.128
=26.37 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Frequently Asked Questions Learn more about Gross Margin % →
What does a Gross Margin % of 26.37% mean?
Ayurcann Holdings (AYURF) has a Gross Margin % of 26.37% as of Sep. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Ayurcann Holdings and its competitors. This is 19% below median its historical median of 32.66. Over the past decade, Ayurcann Holdings' Gross Margin % has ranged from 23.66 to 60.61.
Is Ayurcann Holdings' Gross Margin % too high?
Ayurcann Holdings' current Gross Margin % of 26.37% is 19% below median its 10-year median of 32.66. Over the past 10 years, this metric has ranged from a low of 23.66 to a high of 60.61. The Drug Manufacturers industry median Gross Margin % is 48.46. Ayurcann Holdings' value of 26.37% is 45.6% below this industry median.
How does Ayurcann Holdings' Gross Margin % compare to BSPK and SKYI?
Ayurcann Holdings' Gross Margin % of 26.37% can be compared against companies in the Drug Manufacturers industry. The industry median Gross Margin % is 48.46. Ayurcann Holdings' value of 26.37% is 45.6% below this benchmark. Historically, Ayurcann Holdings' own Gross Margin % has ranged from 23.66 to 60.61 over the past decade. While the company's 10-year median is 32.66 vs. the industry median of 48.46, Ayurcann Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.46, based on 937 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ayurcann Holdings's current Gross Margin % of 26.37% is 45.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Ayurcann Holdings and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ayurcann Holdings's current Gross Margin % is 26.37%, which is 19% below median its own 10-year median of 32.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ayurcann Holdings stock overvalued right now?
Ayurcann Holdings (AYURF) has a current Gross Margin % of 26.37%. The stock's GF Value™ is $0.01, compared to a current price of $0.00 — trading 79% below its estimated fair value. The current Gross Margin % is 26.37%, which is 19% below median its 10-year median of 32.66 and 45.6% below the Drug Manufacturers industry median of 48.46. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Ayurcann Holdings (AYURF), the current Gross Margin % is 26.37% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ayurcann Holdings Business Description

Address 1080 Brock Road, Unit 6, Pickering, ON, CAN, L1W 3H3
Ayurcann Holdings Corp is engaged in providing post-harvest outsourcing solutions to licensed cannabis producers and the manufacture and distribution of cannabis products.